Summit Partners Public Asset Management, LLC Nevro Corp Transaction History

Summit Partners Public Asset Management, LLC

$4.13 Billion
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $8.53 Million - $11.4 Million	-61,729 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$114.09 - $145.51 $7.04 Million - $8.98 Million	61,729 New	61,729 $8.6 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $2.31 Million - $3.27 Million	-35,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $2.83 Million - $3.19 Million	35,000	35,000 $3.18 Million

Others Institutions Holding NVRO

# of Institutions

145

Shares Held

37.6M

Call Options Held

622K

Put Options Held

1.39M

Arrow Mark Colorado Holdings LLC Denver, CO

4.36M
Shares

$25.2 Million
0.24% of portfolio
Armistice Capital, LLC New York, NY

3.74M
Shares

$21.6 Million
0.2% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$20.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.06M
Shares

$11.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

1.8M
Shares

$10.4 Million
0.01% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $204M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account